{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:15:26Z","timestamp":1793754926548,"version":"4.6.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>The Sarcoidosis Diagnostic Score (SDS) has been established to quantitate the clinical features consistent with sarcoidosis in a monocentric study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We aimed to confirm the diagnostic value of SDS in a large, multicontinental study and to assess the utility of SDS in differentiating sarcoidosis from alternative diagnoses, including infectious and noninfectious granulomatous diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included patients with biopsy-confirmed sarcoidosis at nine centers across the world. Patients without sarcoidosis seen at the same sites served as control patients. Using a modified World Association of Sarcoidosis and Other Granulomatous Disorders organ assessment instrument, we scored all patients for the presence of granuloma on biopsy, highly probable symptoms, and least probable symptoms for each area. Two sarcoidosis scores were generated: SDS Biopsy (with biopsy) and SDS Clinical (without biopsy). SDS Clinical and Biopsy were calculated for all patients. We calculated and compared the area under the curve (AUC) for SDS Clinical and Biopsy according to different diagnosis scenarios.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1,041 patients with sarcoidosis and 1,035 without sarcoidosis were included. The results for SDS Clinical (AUC, 0.888; 95% confidence interval [CI], 0.874\u20130.902) and SDS Biopsy (AUC, 0.979; 95% CI, 0.973\u20130.985) according to AUC were good to excellent for differentiating sarcoidosis from alternative diagnosis. SDS Clinical was less discriminatory in males (P\u2009=\u20090.01) and in high tuberculosis prevalence centers (P\u2009&amp;lt;\u20090.001). However, SDS Clinical (AUC, 0.684; 95% CI, 0.602\u20130.766) and SDS Biopsy (AUC, 0.754; 95% CI, 0.673\u20130.835) were not sufficiently discriminative for noninfectious granulomatous diseases, but both SDSs could differentiate sarcoidosis from infectious granulomatous diseases. Algorithms were proposed for the SDS Clinical and SDS Biopsy to assist the clinician in the diagnostic process, and cutoff values were proposed for the SDS Clinical and SDS Biopsy, allowing the diagnosis of sarcoidosis to be safely confirmed or rejected in most cases except for noninfectious granulomatous disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This multicontinental study confirms that both SDS Clinical and SDS Biopsy have good to excellent performance in discriminating sarcoidosis from alternative diagnoses. Differences in the AUC were seen for high tuberculosis prevalence versus low tuberculosis prevalence centers and for males versus females. Both SDSs had good discriminatory function for infectious granulomatous disease but failed in cases of noninfectious granulomatous disease such as berylliosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202206-529oc","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T12:41:11Z","timestamp":1667392871000},"page":"371-380","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":13,"title":["Validation of the Sarcoidosis Diagnostic Score in a Multicontinental Study"],"prefix":"10.1093","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4070-5569","authenticated-orcid":false,"given":"Florence","family":"Jeny","sequence":"first","affiliation":[{"name":"Institut national de la sante et de la recherche medicale, Unit\u00e9 mixte de recherche 1272, Universit\u00e9 Sorbonne Paris-Nord, Bobigny, France"},{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris, Service de Pneumologie, H\u00f4pital Avicenne, Bobigny, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violetta","family":"Vucinic","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Belgrade, Belgrade, Serbia"},{"name":"University Clinic for Pulmonary Diseases, Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Shanghai Pulmonary Hospital of Tongji University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Valeyre","sequence":"additional","affiliation":[{"name":"Institut national de la sante et de la recherche medicale, Unit\u00e9 mixte de recherche 1272, Universit\u00e9 Sorbonne Paris-Nord, Bobigny, France"},{"name":"Groupe Hospitalier Paris Saint Joseph, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parathasarathi","family":"Bhattacharyya","sequence":"additional","affiliation":[{"name":"Institute of Pulmocare and Research, Kolkata, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra N.","family":"Bickett","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Judson","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, Albany Medical College, Albany, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ogugua Ndili","family":"Obi","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care & Sleep Medicine, Brody School of Medicine, East Carolina University, Greenville, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques E.","family":"Denis","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care & Sleep Medicine, Brody School of Medicine, East Carolina University, Greenville, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Talwar","sequence":"additional","affiliation":[{"name":"Metro Centre for Respiratory Diseases, Noida, India; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Strambu","sequence":"additional","affiliation":[{"name":"University of Medicine and Pharmacy \u201cCarol Davila,\u201d Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse E.","family":"Lower","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Baughman","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"2026012203262157400_bib1","first-page":"736","article-title":"Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999","volume":"160","author":"ATS\/ERS\/WASOG","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203262157400_bib2","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203262157400_bib3","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.chest.2018.05.003","article-title":"Sarcoidosis diagnostic score: a systematic evaluation to enhance the diagnosis of sarcoidosis","volume":"154","author":"Bickett","year":"2018","journal-title":"Chest"},{"key":"2026012203262157400_bib4","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026012203262157400_bib5","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.chest.2018.06.012","article-title":"The diagnosis of sarcoidosis: attempting to apply rigor to arbitrary and circular reasoning","volume":"154","author":"Judson","year":"2018","journal-title":"Chest"},{"key":"2026012203262157400_bib6","doi-asserted-by":"crossref","first-page":"170012","DOI":"10.1183\/16000617.0012-2017","article-title":"Differential diagnosis of granulomatous lung disease: clues and pitfalls: number 4 in the Series \u201cPathology for the clinician\u201d Edited by Peter Dorfm\u00fcller and Alberto Cavazza","volume":"26","author":"Ohshimo","year":"2017","journal-title":"Eur Respir Rev"},{"key":"2026012203262157400_bib7","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/17476348.2020.1794827","article-title":"Granulomatous lung disease: clinical aspects","volume":"14","author":"Chopra","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"2026012203262157400_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jbi.2012.10.006","article-title":"Procurement of shared data instruments for Research Electronic Data Capture (REDCap)","volume":"46","author":"Obeid","year":"2013","journal-title":"J Biomed Inform"},{"key":"2026012203262157400_bib9","doi-asserted-by":"crossref","first-page":"e1002119","DOI":"10.1371\/journal.pmed.1002119","article-title":"Sex differences in tuberculosis burden and notifications in low- and middle-income countries: a systematic review and meta-analysis","volume":"13","author":"Horton","year":"2016","journal-title":"PLoS Med"},{"key":"2026012203262157400_bib10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.200402-190OC","article-title":"Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk","volume":"171","author":"Newman","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203262157400_bib11","first-page":"380","article-title":"Epidemiologic patterns of disease expression in sarcoidosis: age, gender and ethnicity-related differences","volume":"34","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2026012203262157400_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00408-016-9952-6","article-title":"Influence of gender on epidemiology and clinical manifestations of sarcoidosis: a population-based retrospective cohort study 1976-2013","volume":"195","author":"Ungprasert","year":"2017","journal-title":"Lung"},{"key":"2026012203262157400_bib13","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203262157400_bib14","first-page":"1052","article-title":"Geoepidemiological big data approach to sarcoidosis: geographical and ethnic determinants","volume":"37","author":"Brito-Zer\u00f3n","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2026012203262157400_bib15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0034-1377059","article-title":"Sarcoidosis and chronic beryllium disease: similarities and differences","volume":"35","author":"Mayer","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"2026012203262157400_bib16","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1183\/09031936.06.00112205","article-title":"Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients","volume":"27","author":"M\u00fcller-Quernheim","year":"2006","journal-title":"Eur Respir J"},{"key":"2026012203262157400_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1183\/09031936.00189011","article-title":"Granulomatosis-associated common variable immunodeficiency disorder: a case-control study versus sarcoidosis","volume":"41","author":"Bouvry","year":"2013","journal-title":"Eur Respir J"},{"key":"2026012203262157400_bib18","doi-asserted-by":"crossref","first-page":"bcr2014206016","DOI":"10.1136\/bcr-2014-206016","article-title":"Coexistence of pulmonary tuberculosis and sarcoidosis: a diagnostic dilemma","volume":"2014","author":"Mandal","year":"2014","journal-title":"BMJ Case Rep"},{"key":"2026012203262157400_bib19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1378\/chest.114.2.363","article-title":"Can tuberculosis cause sarcoidosis? New techniques try to answer an old question","volume":"114","author":"Baughman","year":"1998","journal-title":"Chest"},{"key":"2026012203262157400_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1378\/chest.113.1.147","article-title":"Mediastinoscopy in patients with presumptive stage I sarcoidosis: a risk\/benefit, cost\/benefit analysis","volume":"113","author":"Reich","year":"1998","journal-title":"Chest"},{"key":"2026012203262157400_bib21","doi-asserted-by":"crossref","first-page":"106564","DOI":"10.1016\/j.rmed.2021.106564","article-title":"The impact of demographic disparities in the presentation of sarcoidosis: a multicenter prospective study","volume":"187","author":"Zhou","year":"2021","journal-title":"Respir Med"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/20\/3\/371\/66270518\/annalsats_20_3_371.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/20\/3\/371\/66270518\/annalsats_20_3_371.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:26:49Z","timestamp":1769070409000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/20\/3\/371\/8414916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3,1]]},"published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202206-529oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"assertion":[{"value":"2022-06-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}